HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiko Kawahara Selected Research

Proteins (Proteins, Gene)

1/2022AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer.
9/2019Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
1/2019Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients.
9/2018Copy number gain in recurrent anaplastic lymphoma kinase (ALK) rearrangement-lung adenocarcinoma in the pleural effusion.
5/2018HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report.
3/2018Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
10/2016The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients.
8/2015Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
8/2015Assessment of cell proliferation in renal cell carcinoma using dual-phase 18F-fluorodeoxyglucose PET/CT.
5/2013Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akihiko Kawahara Research Topics

Disease

87Neoplasms (Cancer)
11/2023 - 11/2003
37Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 06/2009
15Lung Neoplasms (Lung Cancer)
01/2022 - 09/2009
9Carcinoma (Carcinomatosis)
11/2023 - 11/2014
9Neoplasm Metastasis (Metastasis)
01/2022 - 12/2008
9Breast Neoplasms (Breast Cancer)
01/2020 - 03/2008
8Colorectal Neoplasms (Colorectal Cancer)
12/2019 - 07/2011
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 04/2012
5Stomach Neoplasms (Stomach Cancer)
07/2020 - 08/2010
5Adenocarcinoma of Lung
06/2019 - 02/2014
4Squamous Cell Carcinoma of Head and Neck
02/2024 - 01/2020
4Pancreatic Neoplasms (Pancreatic Cancer)
06/2023 - 06/2006
4Adenocarcinoma
05/2021 - 07/2011
3Insulinoma
09/2019 - 03/2018
3Pleural Effusion (Pleural Effusions)
09/2019 - 02/2014
2Cachexia
10/2023 - 01/2023
2Hypoxia (Hypoxemia)
02/2023 - 04/2013
2Fatigue
01/2023 - 03/2013
2Esophageal Squamous Cell Carcinoma
08/2021 - 10/2016
2Triple Negative Breast Neoplasms
01/2020 - 07/2014
2Renal Cell Carcinoma (Grawitz Tumor)
11/2018 - 08/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2018 - 03/2018
2Melanoma (Melanoma, Malignant)
11/2017 - 06/2009
2Lymphatic Metastasis
01/2014 - 05/2012
2Carcinogenesis
06/2012 - 07/2011
2Papillary Thyroid Cancer
10/2011 - 08/2011
1Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2023
1Disease Progression
01/2023
1Weight Gain
01/2023
1Dysgeusia (Parageusia)
01/2023
1Dizziness (Lightheadedness)
01/2023

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2006
15ErbB Receptors (EGF Receptor)IBA
09/2017 - 09/2009
14Biomarkers (Surrogate Marker)IBA
10/2023 - 09/2009
10LigandsIBA
02/2024 - 03/2015
9Immune Checkpoint InhibitorsIBA
10/2023 - 11/2017
9Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2011
8B7-H1 AntigenIBA
02/2023 - 01/2017
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 06/2009
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2018 - 08/2011
8Peptides (Polypeptides)IBA
05/2016 - 04/2012
7Fluorine-18IBA
01/2020 - 07/2010
7DNA (Deoxyribonucleic Acid)IBA
09/2018 - 06/2010
7Gefitinib (Iressa)FDA Link
01/2014 - 06/2010
6Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2017 - 06/2010
5AntibodiesIBA
11/2014 - 06/2010
4SynaptophysinIBA
09/2019 - 08/2012
4Transcription Factors (Transcription Factor)IBA
01/2017 - 02/2013
4Monoclonal AntibodiesIBA
10/2016 - 11/2014
4MucinsIBA
11/2014 - 04/2012
4Phosphotransferases (Kinase)IBA
08/2014 - 06/2009
3Cell-Free Nucleic AcidsIBA
06/2023 - 10/2015
3Carboplatin (JM8)FDA LinkGeneric
01/2021 - 06/2009
3Anaplastic Lymphoma KinaseIBA
09/2018 - 11/2014
3VimentinIBA
02/2018 - 11/2003
3Cadherins (E-Cadherin)IBA
02/2018 - 06/2012
3ChromatinIBA
02/2018 - 07/2008
3Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2014 - 07/2010
3Tyrosine Kinase InhibitorsIBA
01/2014 - 01/2012
3matrigelIBA
01/2014 - 06/2006
3CateninsIBA
07/2012 - 07/2011
2S100 Proteins (S 100 Protein)IBA
11/2023 - 06/2011
2Capsules (Microcapsules)IBA
11/2023 - 01/2016
2Forkhead Transcription Factors (Forkhead Box Proteins)IBA
02/2023 - 07/2013
2entrectinibIBA
01/2023 - 01/2022
2Carcinoembryonic AntigenIBA
08/2022 - 11/2003
2osimertinibIBA
01/2022 - 09/2017
2PlatinumIBA
01/2021 - 01/2013
2Estrogen Receptor Modulators (Antiestrogen)IBA
01/2020 - 01/2017
2Keratins (Keratin)IBA
05/2018 - 04/2018
2Estrogen Receptor alphaIBA
01/2018 - 03/2008
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2017 - 10/2013
2AfatinibIBA
09/2017 - 08/2014
2Cancer VaccinesIBA
05/2016 - 10/2013
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2015 - 05/2015
2Phenobarbital (Luminal)FDA Link
07/2015 - 11/2002
2Paclitaxel (Taxol)FDA LinkGeneric
01/2014 - 06/2009
2Docetaxel (Taxotere)FDA Link
11/2013 - 08/2009
2CytokinesIBA
08/2013 - 04/2011
2Indicators and Reagents (Reagents)IBA
04/2013 - 05/2012
2Insulin (Novolin)FDA Link
02/2013 - 07/2011
2locked nucleic acidIBA
01/2013 - 10/2011
2Peptide Nucleic AcidsIBA
01/2013 - 10/2011
2EnzymesIBA
06/2012 - 08/2010
2Claudin-1IBA
06/2012 - 07/2011
2Small Interfering RNA (siRNA)IBA
05/2012 - 03/2008
2TubulinIBA
08/2009 - 06/2009
1GhrelinIBA
10/2023
1OsteopontinIBA
10/2023
1C-Reactive ProteinIBA
10/2023

Therapy/Procedure

14Therapeutics
02/2023 - 08/2009
11Drug Therapy (Chemotherapy)
01/2023 - 06/2009
9Immunotherapy
10/2023 - 04/2012
4Radiotherapy
02/2023 - 05/2012
3Aftercare (After-Treatment)
01/2019 - 10/2015
2Chemoradiotherapy
01/2021 - 03/2016
2Gastrectomy
07/2020 - 04/2013
2Neoadjuvant Therapy
11/2017 - 11/2013
1Brachytherapy
02/2023
1Precision Medicine
01/2023